Viewing data from:

METHOTREXATE SODIUM

ANDA

METHOTREXATE SODIUM | A201749 | SUN PHARMACEUTICAL INDUSTRIES LTD

1 strength0 unique patents0 unique exclusivities

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 2 NDCs

Highest NADAC/Unit

$0.1635

per ea

Lowest NADAC/Unit

$0.1635

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
47335023583METHOTREXATE 2.5 MG TABLET	$0.1635	EA	Generic	—	2026-06-17
47335023596METHOTREXATE 2.5 MG TABLET	$0.1635	EA	Generic	—	2026-06-17

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

VA Federal Supply Schedule

Government-negotiated contract prices | 2 NDCs (2 FSS)

Lowest Price

$13.25

Highest Price

$22.82

FSS NDCs

Big4 NDCs

Description	Price	Type	Vendor	Contract End
47335-0235-83METHOTREXATE NA 2.5MG TAB	$22.82	FSS	Sun Pharmaceutical Industries, Inc.	07/14/2026
47335-0235-96METHOTREXATE NA 2.5MG TAB	$13.25	FSS	Sun Pharmaceutical Industries, Inc.	07/14/2026

Source: VA Federal Supply Schedule (va.gov). Prices are government-negotiated contract prices.

API Supply Chain4 active DMFs2 inactive

4 active API suppliers hold Drug Master Files for this ingredient.

EXCELLA GMBH AND CO KGMETHOTREXATE SODIUM

DMF 124721997

ALEMBIC PHARMACEUTICALS LTDMETHOTREXATE SODIUM

DMF 362772021

MSN LABORATORIES PRIVATE LTDMETHOTREXATE SODIUM

DMF 426272025

SHILPA PHARMA LIFESCIENCES LTDMETHOTREXATE SODIUM

DMF 427952025

BEN VENUE LABORATORIES INCInactiveMETHOTREXATE SODIUM FOR INJECTION, LYOPHILIZED

DMF 61221985

LACHEMA BRNOInactiveMETHOTREXATE SODIUM

DMF 95261992

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (1)

#001 — EQ 2.5MG BASE

0 patents0 exclusivities▴

TABLET;ORAL | Approved: May 21, 2015

No patent or exclusivity listings for this strength.